pioglitazone and raloxifene hydrochloride
pioglitazone has been researched along with raloxifene hydrochloride in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Simorre, B | 1 |
Enami, T; Hoenen, T; Imamura, K; Inoue, H; Kawaguchi, J; Nishi, Y; Ohta, A; Okada, S; Sakurai, Y; Shibukawa, R; Shu, T; Yasuda, J | 1 |
Other Studies
2 other study(ies) available for pioglitazone and raloxifene hydrochloride
Article | Year |
---|---|
[41th Congress of EASD (European Association for The Study of Diabetes) 10 to 15 September 2005, Athens, Greece].
Topics: Aged; Albuminuria; Antihypertensive Agents; Bone Density Conservation Agents; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Multicenter Studies as Topic; Pioglitazone; Prospective Studies; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Spironolactone; Thiazolidinediones; Time Factors | 2006 |
iPSC screening for drug repurposing identifies anti-RNA virus agents modulating host cell susceptibility.
Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; COVID-19 Drug Treatment; Drug Repositioning; Ebolavirus; Humans; Induced Pluripotent Stem Cells; Microbial Sensitivity Tests; Pioglitazone; Raloxifene Hydrochloride; RNA Viruses; RNA, Viral; SARS-CoV-2; Selective Estrogen Receptor Modulators; Sendai virus; Vero Cells | 2021 |